Skip to main content
Thorax logoLink to Thorax
. 1988 Apr;43(4):265–267. doi: 10.1136/thx.43.4.265

Predicted values: how should we use them?

M R Miller, A C Pincock
PMCID: PMC461211  PMID: 3406912

Full text

PDF
265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eliasson O., Degraff A. C., Jr The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. Am Rev Respir Dis. 1985 Oct;132(4):858–864. doi: 10.1164/arrd.1985.132.4.858. [DOI] [PubMed] [Google Scholar]
  2. Miller M. R., Pincock A. C., Grove D. M. Patterns of spirogram abnormality in individual smokers. Am Rev Respir Dis. 1985 Nov;132(5):1034–1040. doi: 10.1164/arrd.1985.132.5.1034. [DOI] [PubMed] [Google Scholar]
  3. Oliver L. C., Eisen E. A., Sprince N. L. A comparison of two definitions of abnormality on pulmonary outcome in epidemiologic studies. Am Rev Respir Dis. 1986 May;133(5):825–829. [PubMed] [Google Scholar]
  4. Sobol B. J. Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility. Thorax. 1966 Sep;21(5):445–449. doi: 10.1136/thx.21.5.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Tweeddale P. M., Alexander F., McHardy G. J. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax. 1987 Jul;42(7):487–490. doi: 10.1136/thx.42.7.487. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES